Table 1.
Condition | Blocking Drug Dose (mg/kg) | Globus pallidus | Caudate | Putamen | Cingulate cortex | Insula | Frontal cortex | Temporal cortex | Thalamus | Cerebellum |
---|---|---|---|---|---|---|---|---|---|---|
VT (mL·cm−3) | ||||||||||
Baseline (n = 6) | – | 12.7 ± 1.6 | 8.2 ± 1.4 | 8.1 ± 1.2 | 9.6 ± 2.0 | 8.4 ± 1.3 | 6.4 ± 1.0 | 6.1 ± 0.8 | 6.0 ± 0.9 | 4.0 ± 0.6 |
Naloxone (n = 2) | 1.0 | 5.2 ± 0.6 | 4.9 ± 0.6 | 5.3 ± 0.8 | 4.9 ± 1.0 | 4.6 ± 0.7 | 4.4 ± 0.8 | 4.1 ± 0.5 | 4.8 ± 0.8 | 4.3 ± 0.6 |
LY2456302 (n = 1) | 0.03 | 5.2 | 4.4 | 4.2 | 4.9 | 4.2 | 3.7 | 3.5 | 4.3 | 3.2 |
LY2456302 (n = 1) | 0.3 | 4.2 | 4.2 | 4.4 | 4.2 | 3.8 | 3.7 | 3.7 | 4.2 | 3.8 |
LY2459989 (n = 2) | 0.036 | 6.5 ± 2.1 | 5.3 ± 1.3 | 5.0 ± 0.8 | 5.6 ± 1.6 | 5.1 ± 1.3 | 4.5 ± 0.9 | 4.3 ± 0.6 | 4.9 ± 0.8 | 3.9 ± 0.1 |
11C–LY2795050 baseline (n = 4)2 | 5.2 ± 1.4 | 3.0 ± 1.4 | 4.2 ± 0.5 | 3.7 ± 1.4 | 3.4 ± 1.0 | 3.0 ± 1.1 | 2.8 ± 0.9 | – | 2.4 ± 0.6 | |
BPND | ||||||||||
Baseline (n = 6) | – | 2.18 ± 0.23 | 1.04 ± 0.13 | 1.03 ± 0.15 | 1.39 ± 0.25 | 1.08 ± 0.09 | 0.59 ± 0.09 | 0.51 ± 0.08 | 0.50 ± 0.11 | – |
Naloxone (n = 2) | 1.0 | 0.20 ± 0.04 | 0.13 ± 0.02 | 0.23 ± 0.00 | 0.14 ± 0.07 | 0.07 ± 0.01 | 0.02 ± 0.03 | –0.03 ± 0.02 | 0.10 ± 0.03 | – |
LY2456302 (n = 1) | 0.03 | 0.64 | 0.37 | 0.32 | 0.53 | 0.31 | 0.15 | 0.09 | 0.34 | – |
LY2456302 (n = 1) | 0.3 | 0.09 | 0.10 | 0.16 | 0.11 | 0.01 | –0.02 | –0.04 | 0.12 | – |
LY2459989 (n = 2) | 0.036 | 0.67 ± 0.22 | 0.36 ± 0.25 | 0.30 ± 0.19 | 0.44 ± 0.30 | 0.31 ± 0.23 | 0.16 ± 0.17 | 0.10 ± 0.11 | 0.25 ± 0.20 | – |
11C–LY2795050 baseline (n = 4)2 | 0.97 ± 0.10 | 0.32 ± 0.26 | 0.66 ± 0.25 | 0.63 ± 0.21 | 0.39 ± 0.17 | 0.30 ± 0.16 | 0.15 ± 0.12 | – | – |
Mean ± SD, where applicable;
Taken from reference (29).